Zofran

Zofran (ondansetron) was approved to treat nausea during chemotherapy and following surgery by blocking serotonin in the areas of the brain that trigger nausea and vomiting.

Between 2002 and 2004, Zofran's manufacturer began promoting it for the treatment of morning sickness during pregnancy, even though the drug has not been approved for pregnant women and there had been no studies of the side effects in pregnant women. The FDA has received nearly 500 reports of birth defects linked to Zofran. Birth defect risks include cleft palate and septal heart defects.

If you or someone you love has become victim of these side effects, you need to act today and speak with a lawyer who can help obtain compensation for your injuries. Dimopoulos Injury Law is here to help. Call (702) 800-6000 or fill out the contact form and someone will contact you.